$100.26
-0.98 (-0.97%)
At Close: Jul 31, 2026
IXJ: Long-Term Buy On Global Healthcare Tailwinds
04:19pm, Monday, 09'th Jan 2023
iShares Global Healthcare ETF has beaten the S&P 500 over the past 5 years while having less volatility. The IXJ ETF is full of high-quality companies and is globally diversified, lowering the risk of
IXJ Has A Shot At Earnings Growth But Is Still Too Expensive
02:55am, Saturday, 15'th Oct 2022
Earnings growth can happen in this ETF, which is supported by some insurance economics, but also simple demographics and resilient healthcare demand. Earnings growth is hard to come by in current mark
IXJ Is Resilient But No Strong Angle
12:27pm, Friday, 05'th Aug 2022
IXJ gives you very broad-based healthcare exposure. But the bet isn't narrow enough to provide a strong angle or particularly good value.
IXJ: Healthcare Dashboard For May
09:23am, Thursday, 19'th May 2022
Pharmaceuticals and biotechnology are cheap relative to 11-year valuation averages. Life science tools and healthcare equipment are overvalued.
IXJ: A Healthcare ETF For Long Term Hold
01:42pm, Wednesday, 16'th Mar 2022
After poor performance during 2015 to 2018, IXJ reshuffled its portfolio. Price return in the past 3 years is good and even better in the longer period.
Bank of America Corp DE Has $118.32 Million Stake in iShares Global Healthcare ETF (NYSEARCA:IXJ)
09:20am, Wednesday, 22'nd Dec 2021 ETF Daily News
Bank of America Corp DE decreased its position in shares of iShares Global Healthcare ETF (NYSEARCA:IXJ) by 7.2% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,423,480 shares of the companys stock after selling 111,255 shares during the period. [] The post Bank of America Corp DE Has $118.32 Million Stake in iShares Global Healthcare ETF (NYSEARCA:IXJ) appeared first on ETF Daily News .
Kestra Advisory Services LLC Has $341,000 Holdings in iShares Global Healthcare ETF (NYSEARCA:IXJ)
09:24am, Monday, 20'th Dec 2021 Dakota Financial News
Kestra Advisory Services LLC lifted its holdings in iShares Global Healthcare ETF (NYSEARCA:IXJ) by 8.6% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,067 shares of the companys stock after acquiring an additional 321 shares during the period. Kestra Advisory Services LLCs holdings in iShares Global []
IXJ: Healthcare Dashboard For December
04:07am, Friday, 17'th Dec 2021
Pharma/biotech is the most attractive subsector. The most overvalued one is life science tools. IXJ: an alternative to XLV.
Medical Device ETF Debuts
04:35pm, Wednesday, 23'rd Jun 2021
'MDEV' is the first ETF focused solely on global medical device makers.
Traders Look to Buy Global Health Care Stocks
06:30pm, Saturday, 27'th Feb 2021
The patterns forming on the long-term charts suggest that the global health care sector could be poised for a prolonged move higher.
Best And Worst Q1 2021: Healthcare ETFs And Mutual Funds
10:49am, Wednesday, 03'rd Feb 2021
Best And Worst Q1 2021: Healthcare ETFs And Mutual Funds
Best And Worst Q4 2020: Healthcare ETFs And Mutual Funds
10:18am, Thursday, 05'th Nov 2020
The Healthcare sector ranks eighth in Q4'20. Based on an aggregation of ratings of the 359 stocks in the Healthcare sector.
Advisory Alpha LLC Sells 220 Shares of iShares Global Healthcare ETF (NYSEARCA:IXJ)
08:26am, Saturday, 02'nd May 2020
Advisory Alpha LLC cut its holdings in iShares Global Healthcare ETF (NYSEARCA:IXJ) by 31.9% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fun
iShares Global Healthcare ETF (NYSEARCA:IXJ) Position Trimmed by Clarity Wealth Advisors LLC
10:07am, Thursday, 30'th Apr 2020
Clarity Wealth Advisors LLC trimmed its holdings in shares of iShares Global Healthcare ETF (NYSEARCA:IXJ) by 0.7% in the first quarter, according to its most recent Form 13F filing with the SEC. The
FDA cautions on use of malaria drugs for COVID-19 outside of hospitals
02:15pm, Friday, 24'th Apr 2020
In a statement, the FDA is cautioning against the use of malaria meds chloroquine and hydroxychloroquine outside of the hospital setting for the treatment of COVID-19 due to the risk of adverse heart
Sign In
Buy IXJ